Plunkett Research Online: Orgenesis Inc

ORGENESIS INC (ORGS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cel.....


ORGENESIS INC

Ticker: ORGS
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 503 206-0935
Fax:
Address: 1001 SW 5th Avenue
Portland, OR 97204 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Scott CarmerCEO, Subsidiary
Jacob BenArieCEO, Subsidiary/President, Subsidiary
See More
Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cel.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture